Gene: TERF2IP
Official Full Name: TERF2 interacting proteinprovided by HGNC
Gene Summary: Enables G-rich strand telomeric DNA binding activity and phosphatase binding activity. Involved in several processes, including positive regulation of non-canonical NF-kappaB signal transduction; protection from non-homologous end joining at telomere; and regulation of primary metabolic process. Located in chromosome, telomeric region; cytoplasm; and nuclear body. Part of shelterin complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21795 | TERF2IP Knockout cell line (HeLa) | Human | TERF2IP | 1:3~1:6 | Negative | Online Inquiry |
KO21796 | TERF2IP Knockout cell line (HCT 116) | Human | TERF2IP | 1:2~1:4 | Negative | Online Inquiry |
KO21797 | TERF2IP Knockout cell line (HEK293) | Human | TERF2IP | 1:3~1:6 | Negative | Online Inquiry |
KO21798 | TERF2IP Knockout cell line (A549) | Human | TERF2IP | 1:3~1:4 | Negative | Online Inquiry |
TERF2IP Gene Knockout Cell Lines are genetically modified cell lines designed to disrupt the expression of the TERF2IP gene, which encodes the Telomeric Repeat Binding Factor 2 Interacting Protein. This protein plays a critical role in protecting telomeres, regulating telomerase activity, and maintaining genomic stability. The gene knockout cell lines facilitate the study of telomeric function, cellular senescence, and mechanisms of aging-related diseases by eliminating gene expression through targeted gene editing technologies, such as CRISPR/Cas9.
The primary mechanism of these knockout cell lines involves the introduction of specific mutations to the TERF2IP gene, leading to non-functional mRNA and subsequent absence of functional protein. Researchers can utilize these cell lines to characterize phenotypic changes in cell growth, apoptosis resistance, and DNA damage response, thereby gaining insights into the cellular pathways impacted by disruption of telomere regulation. This research is crucial for advancing our understanding of cancer biology, as telomere dysregulation is often associated with tumorigenesis.
One of the significant advantages of TERF2IP Gene Knockout Cell Lines is their specificity and reliability compared to non-targeted chemical inhibitors or temporary gene silencing approaches. They provide a stable experimental model that enables long-term studies without losing the genetic modifications over time. These cell lines offer a unique opportunity for researchers and clinicians to explore therapeutic strategies aimed at targeting telomere biology, potentially leading to novel interventions for age-related diseases and cancer therapies.
Our company, with years of expertise in the field of genetic engineering and cell line development, ensures high-quality, validated knockout cell lines that empower scientists with reliable tools for groundbreaking research. By choosing TERF2IP Gene Knockout Cell Lines, researchers gain access to cutting-edge resources that can significantly impact their discoveries in telomere biology and its implications in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.